1-4 of 4 results for subject:Boys
Librarians' tools
- Search time
- 0.218 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Boys
- We searched for
- subject_t:Boys OR subject_ses:49319
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
Families with boys with Duchenne muscular dystrophy are anxiously waiting the NICE guidance to be published next week. Can I get an assurance from the Minister that, with this drug already being licensed and available in 18 countries, if NICE approves it, NHS England will bring the funding forward very quickly?
Families with boys with Duchenne muscular dystrophy are anxiously waiting the NICE guidance to be published next week. Can I get an assurance from the Minister that, with this drug already being licensed and available in 18 countries, if NICE approves it, NHS England will bring the funding forward very quickly?
The hon. Gentleman is a doughty campaigner. Although he tempts me to pre-empt the decisions of NICE, I cannot, and it would not be appropriate for me to do so. I am afraid that we will just have to wait for its decisions, which are rightly taken on the best clinical evidence.
The hon. Gentleman is a doughty campaigner. Although he tempts me to pre-empt the decisions of NICE, I cannot, and it would not be appropriate for me to do so. I am afraid that we will just have to wait for its decisions, which are rightly taken on the best clinical evidence.
The hon. Gentleman is a doughty campaigner. Although he tempts me to pre-empt the decisions of NICE, I cannot, and it would not be appropriate for me to do so. I am afraid that we will just have to wait for its decisions, which are rightly taken on the best clinical evidence.
Families with boys with Duchenne muscular dystrophy are anxiously waiting the NICE guidance to be published next week. Can I get an assurance from the Minister that, with this drug already being licensed and available in 18 countries, if NICE approves it, NHS England will bring the funding forward very quickly?
To ask the Secretary of State for Health, what steps he is taking to make translarna available to boys who could benefit from it.
To ask the Secretary of State for Health, what steps he is taking to make translarna available to boys who could benefit from it.
The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance for the National Health Service on whether to fund selected drugs and treatments. NICE is currently evaluating Translarna (ataluren) for the treatment of Duchenne muscular dystrophy through its highly specialised technology programme. The publication date for NICE’s final guidance is to be confirmed.
The NHS in England is legally required to fund drugs and treatments recommended in NICE highly specialised technology guidance within three months of its final guidance being issued. In the absence of guidance from NICE, it is for commissioners to make decisions on whether to fund medicines based on an assessment of the available evidence.
To ask the Secretary of State for Health, what his estimate is of the percentage of boys aged 14 and 15 years using cannabis in each of the last five years for which figures are available. - Tables given.
To ask the Secretary of State for Health, what his estimate is of the percentage of boys aged 14 and 15 years using cannabis in each of the last five years for which figures are available. - Tables given.